The three day event will be held in Newark, New Jersey, and will feature government officials, top-level pharmaceutical executives, CEOs of diverse scientific and clinical enterprises, and other great guest speakers. The conference limits participation to 350 invitees to facilitate networking and relationship building and to enable smaller diverse companies to have a higher profile, greater success with meeting with key stakeholders and better return on their investment. The conferences in the past 10 years have been a terrific opportunity to foster effective, mutually beneficial partnerships between diverse suppliers and large pharmaceutical companies and this year we anticipate our success to grow even more.

 

Read More